The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter study to evaluate the efficacy and standardize radiofrequency ablation therapy for early breast cancer.
 
Takayuki Kinoshita
No Relationships to Disclose
 
Shin Takayama
No Relationships to Disclose
 
Masato Takahashi
Honoraria - AstraZeneca; Daiichi Sankyo/UCB Japan; Eisai; Lilly; MSD; Pfizer
Research Funding - Eisai (Inst); Nippon Kayaku (Inst)
 
Tomomi Fujisawa
Speakers' Bureau - Chugai Pharma; Daiichi Sankyo; Lilly
 
Manabu Futamura
No Relationships to Disclose
 
Naohito Yamamoto
No Relationships to Disclose
 
Tadahiko Shien
Consulting or Advisory Role - Allergan; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin; Lilly; Novartis; Pfizer; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Allergan; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin; Lilly; Nihonkayaku; Novartis; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - Eisai (Inst); Nihonkayaku (Inst)
 
Kenjiro Aogi
Honoraria - AstraZeneca; Becton Dickinson; Chugai Pharma; Daiichi Sankyo/UCB Japan; Eisai; Lilly; Mochida Pharmaceutical Co. Ltd.; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Terumo
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Chugai Pharma; Eisai
 
Tatsuya Ohnishi
No Relationships to Disclose